查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1684344

医疗保健生物融合市场，按技术、按解决方案类型、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Healthcare Bioconvergence Market, By Technology, By Solution Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年医疗保健生物融合市场规模价值为 143,920.32 百万美元，2025 年至 2032 年期间的复合年增长率为 6.90%。

医疗保健生物融合市场-市场动态

**人工智慧药物研发的进步加速了市场的成长**

人工智慧驱动的药物发现正在透过加速新疗法的识别和优化治疗方法的开发，彻底改变医疗保健生物融合市场。领先的製药公司和生物技术新创公司正在将人工智慧与生物资料相结合，以增强精准医疗并简化药物筛选。例如，FDA 已经批准了用于药物再利用的人工智慧驱动平台，而 Insilico Medicine 和 BenevolentAI 等公司正在利用深度学习来识别有前景的候选药物。此外，人工智慧驱动的演算法正在基因组学中用于分析大量数据集，有助于早期疾病检测。美国国立卫生研究院 (NIH) 资助了多个基于人工智慧的研究项目，以提高药物功效并缩短开发时间。随着人工智慧降低成本并提高效率，製药公司越来越多地与科技公司合作，利用机器学习进行药物研发。然而，监管挑战和资料隐私问题仍然是充分发挥人工智慧在药物开发方面的潜力的主要障碍。儘管有这些挑战，人工智慧和生物技术的持续融合将重塑现代医学。

医疗保健生物融合市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 6.90%

根据技术细分，预计人工智慧和大数据整合将在 2024 年占据最大市场份额

根据解决方案类型细分，生物製药是 2024 年领先的解决方案类型

根据应用程式细分，个人化医疗是 2024 年的领先应用

从地区来看，北美是 2024 年最大的收入来源

医疗保健生物融合市场-細項分析：

全球医疗保健生物融合市场根据技术、解决方案类型、应用、最终用户和地区进行细分。

市场根据科技分为四大类：合成生物学、生物电子学、奈米技术、人工智慧与大数据整合。人工智慧和大数据整合引领医疗生物融合市场，推动个人化医疗和预测分析。随后，合成生物学彻底改变了基因编辑和生物材料。奈米技术位居第二，可以实现有针对性的药物输送。生物电子学具有巨大的潜力，可增强神经刺激和即时健康监测应用。

根据解决方案类型，市场分为四类：生物製药、组织工程、生物感测器和人工智慧驱动的诊断。生物製药主导医疗生物融合市场，推动标靶治疗和再生医学的进步。随后，人工智慧驱动的诊断彻底改变了早期疾病检测和精准医疗。接下来是组织工程，它能够实现器官再生。生物感测器在即时监测和个人化医疗保健解决方案中发挥着至关重要的作用。

医疗保健生物融合市场-地理洞察

受生物技术、人工智慧（AI）和精准医疗领域强劲投资的推动，北美在医疗生物融合市场中占据主导地位。美国是主要生物科技公司和研究机构的所在地，製药公司和人工智慧新创企业之间的合作日益增多。美国国立卫生研究院的人工智慧驱动研究计画等政府措施进一步支持了市场成长。欧洲紧随其后，德国、英国和法国等国家在合成生物学、生物工程和数位健康创新方面取得了进展。欧盟委员会已启动资助计划，促进生物融合研究。在亚太地区，在政府政策和私营部门投资的推动下，中国、日本和韩国正在迅速扩大其生物技术和人工智慧能力。尤其是中国，在基因编辑和人工智慧诊断领域处于领先地位。同时，中东和拉丁美洲是新兴市场，对个人化医疗和生物资讯学的投资不断增加。然而，人工智慧和基因改造的监管复杂性和道德问题对不同地区的市场扩张构成了挑战。

医疗保健生物融合市场-竞争格局：

医疗保健生物融合市场竞争激烈，主要参与者专注于整合生物技术、人工智慧 (AI)、奈米技术和工程来推动医疗创新。辉瑞、诺华和罗氏等领先的製药公司正在投资人工智慧驱动的药物研发和生物工程解决方案。 IBM Watson Health 和 Google DeepMind 等科技公司正在透过机器学习和运算生物学增强精准医疗。 Insilico Medicine 和 BenevolentAI 等新创公司正在透过人工智慧驱动的药物开发平台获得关注。此外，麻省理工学院和布罗德研究所等学术机构和研究中心在推动合成生物学和生物资讯学的发展方面发挥着至关重要的作用。合併、收购和策略合作伙伴关係正在塑造竞争格​​局，各公司正在合作利用人工智慧和生物分子的进步。政府资助和创投投资进一步推动创新，尤其是在北美和欧洲。然而，监管部门批准、资料隐私问题以及技术整合的高成本等挑战继续影响市场扩张和竞争。

最新动态：

2023 年 2 月，Peregrine Ventures 启动新的「生物融合」新创公司，结合不同领域的技术来开发创新的生命科学产品。

2022 年 10 月，Century Therapeutics 与 Bristol Myers Squibb 合作开发和商业化 iPSC 衍生的同种异体细胞疗法，透过再生治疗领域的协作创新，增强其市场影响力并推进个人化医疗。

2022年5月，以色列启动了一项为期5年、耗资1.27亿美元的生物融合策略，重点关注工业研发和企业联盟的基础设施，将生物学与电子学、物理学、电脑科学和先进的基因工程相结合。

目录

第 1 章：医疗保健生物融合市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 医疗保健生物融合市场片段（按技术）
    • 医疗保健生物融合市场片段（按解决方案类型）
    • 医疗保健生物融合市场片段（按应用）
    • 医疗保健生物融合市场片段（按最终用户）
    • 医疗保健生物融合市场片段（按国家/地区）
    • 医疗保健生物融合市场片段（按区域）
  • 竞争洞察

第 3 章：医疗保健生物融合关键市场趋势

  • 医疗保健生物融合市场驱动因素
    • 市场驱动因素的影响分析
  • 医疗保健生物融合市场限制
    • 市场限制的影响分析
  • 医疗保健生物融合市场机会
  • 医疗保健生物融合市场未来趋势

第 4 章：医疗生物融合产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：医疗保健生物融合市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：医疗保健生物融合市场格局

  • 2024 年医疗保健生物融合市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：医疗保健生物融合市场 - 按技术

  • 概述
    • 按技术分类的细分市场占有率分析
    • 合成生物学
    • 生物电子学
    • 奈米科技
    • 人工智慧与大数据集成

第 8 章：医疗保健生物融合市场 - 按解决方案类型

  • 概述
    • 按解决方案类型分類的细分市场份额分析
    • 生物製药
    • 组织工程
    • 生物感测器
    • 人工智慧诊断

第 9 章：医疗保健生物融合市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 药物研发
    • 个人化医疗
    • 再生医学
    • 生物电子学
    • 用于药物输送的奈米机器人
    • 诊断和生物感测器
    • 工程生物材料
    • 光遗传学

第 10 章：医疗保健生物融合市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 生技公司
    • 研究机构
    • 诊断实验室

第 11 章：医疗保健生物融合市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美医疗生物融合主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按技术分类）
    • 北美市场规模和预测，按解决方案类型
    • 北美市场规模与预测，按应用划分
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲医疗生物融合主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模和预测（按技术分类）
    • 欧洲市场规模和预测，按解决方案类型
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区医疗生物融合主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依技术分类）
    • 亚太地区市场规模及预测（依解决方案类型）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲医疗生物融合主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依技术分类）
    • 拉丁美洲市场规模及预测（按解决方案类型）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲医疗生物融合主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模和预测（按技术分类）
    • MEA 市场规模和预测（按解决方案类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 12 章：主要供应商分析-医疗生物融合产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Adaptive Biotechnologies Corporation
    • Atomwise, Inc.
    • Berkeley Lights, Inc.
    • BGI Genomics Co., Ltd.
    • BioNTech SE
    • Codexis, Inc.
    • Deep Genomics Inc.
    • Ginkgo Bioworks Holdings, Inc.
    • Illumina, Inc.
    • Inscripta, Inc.
    • Moderna, Inc.
    • NanoString Technologies, Inc.
    • Oxford Nanopore Technologies plc
    • Pacific Biosciences of California, Inc.
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience Corporation
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4880

REPORT HIGHLIGHT

Healthcare Bioconvergence Market size was valued at US$ 143,920.32 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Healthcare Bioconvergence Market integrates biology, engineering, and data science to drive innovation in diagnostics, drug development, and personalized medicine. Bioconvergence refers to the fusion of biological and technological disciplines to enhance healthcare solutions. Advances in synthetic biology, nanotechnology, and artificial intelligence are transforming medical research and patient care. For instance, researchers at MIT have developed AI-powered drug discovery platforms that reduce development time by nearly 50%. The increasing prevalence of chronic diseases, demand for precision medicine, and government initiatives supporting biotech innovation are fueling growth. However, high R&D costs and regulatory complexities pose challenges. The emergence of bio-integrated wearable devices, lab-on-a-chip technology, and 3D bioprinting presents lucrative opportunities. Companies like Moderna and BioNTech are leveraging bioconvergence to enhance mRNA-based therapies, demonstrating the potential for disruptive innovations in treatment. Additionally, collaborations between biotech firms and semiconductor manufacturers, such as Intel's AI-driven healthcare initiatives, are expanding the market's technological scope. The future of healthcare bioconvergence lies in bridging biology with advanced computational and engineering solutions.

Healthcare Bioconvergence Market- Market Dynamics

**Advancements in AI-Powered Drug Discovery accelerating the market growth**

AI-powered drug discovery is revolutionizing the healthcare bioconvergence market by accelerating the identification of novel therapeutics and optimizing treatment development. Leading pharmaceutical firms and biotech startups are integrating AI with biological data to enhance precision medicine and streamline drug screening. For instance, the FDA has approved AI-driven platforms for drug repurposing, while companies like Insilico Medicine and BenevolentAI are utilizing deep learning to identify promising drug candidates. Moreover, AI-driven algorithms are being used in genomics to analyze vast datasets, aiding in early disease detection. The National Institutes of Health (NIH) has funded multiple AI-based research projects to improve drug efficacy and reduce development timelines. With AI reducing costs and enhancing efficiency, pharmaceutical companies are increasingly collaborating with tech firms to leverage machine learning in drug discovery. However, regulatory challenges and data privacy concerns remain key hurdles in fully realizing AI's potential in drug development. Despite these challenges, the ongoing convergence of AI and biotechnology is set to reshape modern medicine.

Healthcare Bioconvergence Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on Technology segmentation, AI & Big Data Integration was predicted to show maximum market share in the year 2024

Based on Solution Type segmentation, Biopharmaceuticals was the leading Solution Type in 2024

Based on Application segmentation, Personalized Medicine was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Healthcare Bioconvergence Market- Segmentation Analysis:

The Global Healthcare Bioconvergence Market is segmented on the basis of Technology, Solution Type, Application, End-User, and Region.

The market is divided into four categories based on Technology: Synthetic Biology, Bioelectronics, Nanotechnology, and AI & Big Data Integration. AI & Big Data Integration leads the healthcare bioconvergence market, driving personalized medicine and predictive analytics. Synthetic Biology follows, revolutionizing gene editing and biomaterials. Nanotechnology ranks next, enabling targeted drug delivery. Bioelectronics holds significant potential, enhancing neurostimulation and real-time health monitoring applications.

The market is divided into four categories based on Solution Type: Biopharmaceuticals, Tissue Engineering, Biosensors, and AI-driven Diagnostics. Biopharmaceuticals dominate the healthcare bioconvergence market, driving advancements in targeted therapies and regenerative medicine. AI-driven Diagnostics follows, revolutionizing early disease detection and precision medicine. Tissue Engineering ranks next, enabling organ regeneration. Biosensors play a crucial role in real-time monitoring and personalized healthcare solutions.

Healthcare Bioconvergence Market- Geographical Insights

North America dominates the healthcare bioconvergence market, driven by strong investments in biotechnology, artificial intelligence (AI), and precision medicine. The U.S., home to major biotech firms and research institutions, has seen increasing collaborations between pharmaceutical companies and AI-driven startups. Government initiatives, such as the NIH's AI-driven research programs, further support market growth. Europe follows closely, with countries like Germany, the UK, and France advancing in synthetic biology, bioengineering, and digital health innovations. The European Commission has launched funding programs to promote bioconvergence research. In the Asia-Pacific region, China, Japan, and South Korea are rapidly expanding their biotech and AI capabilities, fueled by government policies and private sector investments. China, in particular, is leading in gene editing and AI-driven diagnostics. Meanwhile, the Middle East and Latin America are emerging players, with growing investments in personalized medicine and bioinformatics. However, regulatory complexities and ethical concerns around AI and genetic modifications pose challenges to market expansion across different regions.

Healthcare Bioconvergence Market- Competitive Landscape:

The healthcare bioconvergence market is highly competitive, with key players focusing on integrating biotechnology, artificial intelligence (AI), nanotechnology, and engineering to drive medical innovations. Leading pharmaceutical companies such as Pfizer, Novartis, and Roche are investing in AI-powered drug discovery and bioengineering solutions. Tech firms like IBM Watson Health and Google DeepMind are enhancing precision medicine through machine learning and computational biology. Startups such as Insilico Medicine and BenevolentAI are gaining traction with AI-driven drug development platforms. Additionally, academic institutions and research centers, including MIT and the Broad Institute, are playing a crucial role in advancing synthetic biology and bioinformatics. Mergers, acquisitions, and strategic partnerships are shaping the competitive landscape, with companies collaborating to leverage AI and biomolecular advancements. Government funding and venture capital investments further drive innovation, particularly in North America and Europe. However, challenges such as regulatory approvals, data privacy concerns, and the high cost of technology integration continue to impact market expansion and competition.

Recent Developments:

In February 2023, Peregrine Ventures launched new 'bioconvergence' startups, combining technologies from diverse fields to develop innovative life sciences products.

In October 2022, Century Therapeutics and Bristol Myers Squibb partnered to develop and commercialize iPSC-derived allogenic cell therapies, enhancing their market presence and advancing personalized medicine through collaborative innovation in regenerative treatments.

In May 2022, Israel launched a five-year, $127 million bio-convergence strategy, focusing on infrastructure for industrial R&D and company consortiums to integrate biology with electronics, physics, computer science, and advanced genetic engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Atomwise, Inc.
  • Berkeley Lights, Inc.
  • BGI Genomics Co., Ltd.
  • BioNTech SE
  • Codexis, Inc.
  • Deep Genomics Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Illumina, Inc.
  • Inscripta, Inc.
  • Moderna, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Others

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Synthetic Biology
  • Bioelectronics
  • Nanotechnology
  • AI & Big Data Integration

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceuticals
  • Tissue Engineering
  • Biosensors
  • AI-driven Diagnostics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Personalized Medicine
  • Regenerative Medicine
  • Bioelectronics
  • Nanorobotics for Drug Delivery
  • Diagnostic and Biological Sensor
  • Engineered Living Materials
  • Optogenetics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotech Firms
  • Research Institutions
  • Diagnostic Labs

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Healthcare Bioconvergence Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Healthcare Bioconvergence Market Snippet by Technology
    • 2.1.2. Healthcare Bioconvergence Market Snippet by Solution Type
    • 2.1.3. Healthcare Bioconvergence Market Snippet by Application
    • 2.1.4. Healthcare Bioconvergence Market Snippet by End-User
    • 2.1.5. Healthcare Bioconvergence Market Snippet by Country
    • 2.1.6. Healthcare Bioconvergence Market Snippet by Region
  • 2.2. Competitive Insights

3. Healthcare Bioconvergence Key Market Trends

  • 3.1. Healthcare Bioconvergence Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Healthcare Bioconvergence Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Healthcare Bioconvergence Market Opportunities
  • 3.4. Healthcare Bioconvergence Market Future Trends

4. Healthcare Bioconvergence Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Healthcare Bioconvergence Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Healthcare Bioconvergence Market Landscape

  • 6.1. Healthcare Bioconvergence Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Healthcare Bioconvergence Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Synthetic Biology
    • 7.1.3. Bioelectronics
    • 7.1.4. Nanotechnology
    • 7.1.5. AI & Big Data Integration

8. Healthcare Bioconvergence Market - By Solution Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
    • 8.1.2. Biopharmaceuticals
    • 8.1.3. Tissue Engineering
    • 8.1.4. Biosensors
    • 8.1.5. AI-driven Diagnostics

9. Healthcare Bioconvergence Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Regenerative Medicine
    • 9.1.5. Bioelectronics
    • 9.1.6. Nanorobotics for Drug Delivery
    • 9.1.7. Diagnostic and Biological Sensor
    • 9.1.8. Engineered Living Materials
    • 9.1.9. Optogenetics

10. Healthcare Bioconvergence Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotech Firms
    • 10.1.4. Research Institutions
    • 10.1.5. Diagnostic Labs

11. Healthcare Bioconvergence Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Healthcare Bioconvergence Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Healthcare Bioconvergence Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Healthcare Bioconvergence Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Healthcare Bioconvergence Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Healthcare Bioconvergence Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Healthcare Bioconvergence Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Atomwise, Inc.
    • 12.2.3. Berkeley Lights, Inc.
    • 12.2.4. BGI Genomics Co., Ltd.
    • 12.2.5. BioNTech SE
    • 12.2.6. Codexis, Inc.
    • 12.2.7. Deep Genomics Inc.
    • 12.2.8. Ginkgo Bioworks Holdings, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Inscripta, Inc.
    • 12.2.11. Moderna, Inc.
    • 12.2.12. NanoString Technologies, Inc.
    • 12.2.13. Oxford Nanopore Technologies plc
    • 12.2.14. Pacific Biosciences of California, Inc.
    • 12.2.15. Thermo Fisher Scientific Inc.
    • 12.2.16. Twist Bioscience Corporation
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us